Experts Join IRIS Condemnation of Sharon Treatment

Three days ago, I paraphrased my neurologist's assessment of Sharon's apparent treatment following his first stroke as "hopelessly contradicted by medical norms." A neurologist is as likely to prescribe aggressive anticoagulants (e.g. Heparin) for a stroke victim diagnosed with CAA as he is to advise a cobra resolve a home mice infestation. Both are technically adequate, but present bigger risks than they solve. For example, one causes brain hemorrhages.

Two articles now present neurologists who share this assessment. Here is one:

Meanwhile, a prominent neurologist yesterday joined the chorus that has been questioning the prime minister's treatment ever since Haaretz reported that Sharon suffered from Cerebral Amyloid Angiopathy (CAA), a disease affecting the blood vessels of the brain.

Dr. Steven Greenberg, Associate Professor of Neurology at Harvard Medical School in Boston, said that CAA constitutes a "central risk factor" for the development of a cerebral hemorrhage. He also said that blood thinning medicines of the kind that Sharon received could cause a small hemorrhage to turn into a large one and a catastrophic stroke.

Here is the other who specifically recommended aspirin in this situation, confirming IRIS's entry of December 21.

Additionally, there is now convincing evidence of IRIS's accusation that part of Sharon's mistreatment can be explained as a textbook example of "VIP Syndrome."